↓ Skip to main content

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

Overview of attention for article published in this source, April 2005
Altmetric Badge

Mentioned by

1 news outlet
1 policy source
1 tweeter


182 Dimensions

Readers on

143 Mendeley
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Alpha-glucosidase inhibitors for type 2 diabetes mellitus
DOI 10.1002/14651858.cd003639.pub2
Pubmed ID

F A Van de Laar, P L B J Lucassen, R P Akkermans, E H Van de Lisdonk, G E H M Rutten, C Van Weel, Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C, Floris A Van de Laar, Peter LBJ Lucassen, Reinier P Akkermans, Eloy H Van de Lisdonk, Guy EHM Rutten, Chris Van Weel


Alpha-glucosidase inhibitors such as acarbose or miglitol, have the potential to improve glycemic control in type 2 diabetes mellitus. The true value of these agents, especially in relation to diabetes related mortality and morbidity, has never been investigated in a systematic literature review and meta-analysis.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
United States 2 1%
United Kingdom 2 1%
Indonesia 1 <1%
Spain 1 <1%
Ireland 1 <1%
Japan 1 <1%
India 1 <1%
Canada 1 <1%
Other 1 <1%
Unknown 130 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 27 19%
Student > Master 27 19%
Student > Bachelor 17 12%
Researcher 17 12%
Other 13 9%
Other 42 29%
Readers by discipline Count As %
Medicine and Dentistry 51 36%
Unspecified 22 15%
Agricultural and Biological Sciences 22 15%
Chemistry 15 10%
Biochemistry, Genetics and Molecular Biology 11 8%
Other 22 15%